Heart rhythm and conduction disorders as manifestations of cardiotoxicity of anticancer treatment: myth or reality?-Reference-Cited by-同舟云学术

Heart rhythm and conduction disorders as manifestations of cardiotoxicity of anticancer treatment: myth or reality?

Published:2020-04-12 Issue:1 Volume:35 Page:13-21
ISSN:2073-8552
Container-title:The Siberian Medical Journal
language:
Short-container-title:SMJ

Author:

Vasyuk Yu. A.¹^ORCID,Shupenina E. Y.¹^ORCID,Novosel E. O.¹^ORCID,Agapov I. S.¹^ORCID

Affiliation:

1. A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Publisher

Cardiology Research Institute

Reference29 articles.

1. Vasyuk Y.A., Yushchuk E.N., Nesvetov V.V. Cardiooncology: a new challenge of our time. Cardiovascular complications of antitumor treatment. Moscow: KlinmedConsulting; 2019:100 (In Russ.).

2. Zamorano J., Lancellotti P., Munoz D., Aboyans V., Asteggiano R., Galderisi M. et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur. Heart J. 2016;37(36):2768–2801. DOI: 10.1093/eurheartj/ehw211.

3. Todaro M., Oreto L., Qamar R., Paterick T., Carerj S., Khandheria B. Cardioncology: state of the heart. Int. J. Cardiol. 2013;168:680–687.

4. Bhave M., Akhter N., Rosen S. Cardiovascular toxicity of biologic agents for cancer therapy. Oncology (Williston Park). 2014;28(6):482–490.

5. Bowles E., Wellman R., Feigelson H., Onitilo A., Freedman A., Delate T. et al. Pharmacovigilance Study Team. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J. Natl. Cancer Inst. 2012;104(17):1293–1305. DOI: 10.1093/jnci/djs317.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remote Monitoring of the QT Interval During Polychemotherapy;Kardiologiia;2023-05-31

2. Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy;Russian Journal of Cardiology;2023-01-05

3. Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future;Rational Pharmacotherapy in Cardiology;2022-03-03

4. Atrial Fibrillation in Cancer Patients: Who is at Risk?;Rational Pharmacotherapy in Cardiology;2022-01-11

5. Cardiotoxic Effects of Yew Tree and Pink Periwinkle Alkaloids;Safety and Risk of Pharmacotherapy;2021-11-08